MOH
Molina Healthcare, Inc.
MOH lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover, though they disagree widely on how much.
MOH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Stable | |
| Strong |
MOH's balance sheet is currently strong, and its revenue and cash flow are stable, but its profitability is under pressure.
MOH PE Valuation
MOH has no meaningful PE right now: it lost money over the past year.
MOH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for MOH, with profitability holding steady. However, they disagree widely on these estimates.
MOH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $8.35 | — |
| Q3 2026 | -$0.60 | -104% |
| Q2 2026 | $0.18 | -99% |
| Q1 2026 | $3.74 | -82% |
| Q4 2025 | $8.92 | -56% |
| Q3 2025 | $16.14 | -18% |
| Q2 2025 | $20.28 | +11% |
| Q1 2025 | $20.70 | +12% |
| Q4 2024 | $20.42 | +8.8% |
MOH has swung to a loss: it lost $0.60 per share over the past year, after a profit the year before.
MOH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.1B | -3.4% |
| Q2 2026 | $10.9B | -4.8% |
| Q1 2026 | $10.8B | -3.1% |
| Q4 2025 | $11.4B | +8.3% |
| Q3 2025 | $11.5B | +11% |
| Q2 2025 | $11.4B | +16% |
| Q1 2025 | $11.1B | +12% |
| Q4 2024 | $10.5B | +16% |
MOH's revenue grew through 2024 and has held roughly level since: $11.1B last quarter, down 3.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1% | -0.2 points |
| Q2 2026 | 1.3% | -1.9 points |
| Q1 2026 | 0.8% | -3.1 points |
| Q4 2025 | -1.4% | -5 points |
| Q3 2025 | 1.2% | -3.3 points |
| Q2 2025 | 3.3% | -1.1 points |
| Q1 2025 | 3.9% | -0.4 points |
| Q4 2024 | 3.6% | +0.1 points |
MOH's operating margin was 1% last quarter, about level with the same quarter a year ago, near the bottom of its range since 2019.
MOH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$196M | -$33M |
| Q2 2026 | -$324M | +$20M |
| Q1 2026 | $1.1B | +528% |
| Q4 2025 | -$297M | -$62M |
| Q3 2025 | -$163M | -119% |
| Q2 2025 | -$344M | -$98M |
| Q1 2025 | $168M | -10% |
| Q4 2024 | -$235M | +$450M |
MOH's free cash flow has turned positive after two years mostly in the red: $238M over the past year.
MOH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +200K shares |
| 1 year | -1.9% | -1M shares |
| 3 years | -11% | -6.6M shares |
| 5 years | -12% | -7M shares |
| Available history | -20% | -12.7M shares |
MOH has 52M diluted shares, down 1.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | $500M |
| Q2 2025 | — |
| Q1 2025 | $500M |
| Q4 2024 | $500M |
MOH hasn't bought back shares in the past year.
MOH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.1x | Net Cash |
| Q2 2026 | -3.3x | Net Cash |
| Q1 2026 | -2.5x | Net Cash |
| Q4 2025 | -0.5x | Net Cash |
| Q3 2025 | -0.4x | Net Cash |
| Q2 2025 | -0.6x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -0.9x | Net Cash |
MOH has more cash than debt.
MOH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 55.8 | Neutral |
MOH's weekly RSI is 56 (neutral) and its Stochastic is 56 (neutral).
MOH PE vs Healthcare Sector
| Metric | MOH | Sector median | Relative |
|---|---|---|---|
| PE | 1,152x | 26x | 4,356% above |
| PE % | 100 | 29 | 71 pts above |
MOH has no meaningful PE right now: it lost money over the past year.
MOH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $202.2 | 3.8% above |
| 20 week MA | $205.7 | 2% above |
| 50 week MA | $183.7 | 14% above |
| 100 week MA | $216.0 | 2.9% below |
| 200 week MA | $271.6 | 23% below |
MOH has bounced recently, but its long-term trend is still down: it's above its 8-, 20- and 50-week averages, but 23% below its 200-week average.
MOH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $136.1 | $207.1 | +52% |
| 2021 | $207.1 | $316.7 | +53% |
| 2022 | $316.7 | $335.1 | +5.8% |
| 2023 | $335.1 | $361.3 | +7.8% |
| 2024 | $361.3 | $292.2 | -19% |
| 2025 | $292.2 | $164.8 | -44% |
| 2026 YTD | $164.8 | $209.9 | +27% |
MOH has finished higher in four of the last six years, two of them by more than 50%. It's up 27% so far in 2026.